Press Releases

Mon, 12 Jun 2017

2021 COMPLETE PROPOSAL BY THE BOARD OF DIRECTORS TO ESTABLISH AN INCENTIVE SCHEME 2017/2021

Styrelsen i Bluefish Pharmaceuticals AB (publ), org. nr. 556673-9164, (”Bolaget”) föreslår att årsstämman beslutar att inrätta ett incitamentsprogram innefattande beslut om bland annat emission av teckningsoptioner samt godkännande av överlåtelse av teckningsoptioner enligt följande.

The Board of Directors of Bluefish Pharmaceuticals AB (publ), reg. no. 556673-9164, (the ”Company”) proposes that the Annual General Meeting resolves to establish an incentive scheme, consisting of, inter alia, issuance of warrants and approval of transferring warrants, in accordance with what is set out below.

 

For more information, contact

 

Berit Lindholm, CEO Bluefish Pharmaceuticals 

Tel. 46 8 519 116 00

Email: berit.lindholm@bluefishpharma.com

 

COMPLETE PROPOSAL BY THE BOARD OF DIRECTORS TO ESTABLISH AN INCENTIVE SCHEME 2017/2021